相关实验视频
Updated: Jul 2, 2025

05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
710
在使用软凝固治疗的血液静止后,从肋间动脉伪动脉瘤中出现晚期出血的情况
Rie Shimizu1, Kenichi Suda2, Toshiki Takemoto1
1Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8581, Japan.
Surgical case reports
|February 28, 2024
概括
软凝血是一种常见的胸部手术技术. 这一案例突出了伪动脉瘤的罕见晚出血并发症,这表明小动脉可能需要额外的止血.
科学领域:
- 心血管外科心血管外科
- 胸部外科手术 胸部外科手术
- 血管外科 血管外科
背景情况:
- 软凝血在胸部手术中越来越多地用于快速血液静止.
- 这种技术通过脱水组织和变质蛋白质来实现血静,旨在避免组织燃烧.
研究的目的:
- 报告一个罕见的病例,在胸部手术期间发生软凝血血静止后,从肋间动脉伪动脉瘤中出现晚出血.
- 强调与软凝血相关的潜在风险,特别是涉及小动脉和可疑的组织碳化.
主要方法:
- 一名68岁的男性患者因疑似二次肺癌而接受了部分右上叶切除.
- 在手术期间,从第六条肋间动脉出血是通过软凝固来控制的,并注意到组织碳化.
- 手术后的血栓塞导致通过CT扫描诊断出伪动脉瘤,并用栓塞治疗.
主要成果:
- 该患者在手术后18天因第6条肋间动脉的伪动脉瘤而发生了血栓塞.
- 血管造血栓塞成功控制了伪动脉瘤的出血.
结论:
- 这个案例说明了一个延迟出血并发症,源于与软凝结血静止相关的伪动脉瘤.
- 建议在软凝固后考虑补充的血液静止方法,如绑定,用于小动脉,特别是如果观察到组织碳化.
相关概念视频
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Disorders of Hemostasis
904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696

